| CXCR1-or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors L Jin, H Tao, A Karachi, Y Long, AY Hou, M Na, KA Dyson, AJ Grippin, ... Nature communications 10 (1), 4016, 2019 | 257 | 2019 |
| Dysregulation of glutamate transport enhances treg function that promotes VEGF blockade resistance in glioblastoma Y Long, H Tao, A Karachi, AJ Grippin, L Jin, Y Chang, W Zhang, ... Cancer research 80 (3), 499-509, 2020 | 86 | 2020 |
| The IDH1 mutation-induced oncometabolite, 2-hydroxyglutarate, may affect DNA methylation and expression of PD-L1 in gliomas L Mu, Y Long, C Yang, L Jin, H Tao, H Ge, YE Chang, A Karachi, ... Frontiers in molecular neuroscience 11, 82, 2018 | 78 | 2018 |
| CAR T cell locomotion in solid tumor microenvironment DT Nguyen, E Ogando-Rivas, R Liu, T Wang, J Rubin, L Jin, H Tao, ... Cells 11 (12), 1974, 2022 | 21 | 2022 |
| CXCR1-or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors. Nat. Commun. 10, 4016 L Jin, H Tao, A Karachi, Y Long, AY Hou, M Na, KA Dyson, AJ Grippin, ... Molecular Therapy: Methods & Clinical Development, 2019 | 7 | 2019 |
| Three-dimensional bioconjugated liquid-like solid (LLS) enhance characterization of solid tumor-Chimeric antigen receptor T cell interactions DT Nguyen, R Liu, E Ogando-Rivas, A Pepe, D Pedro, S Qdasait, ... bioRxiv, 2023 | 3 | 2023 |
| Bioconjugated liquid-like solid enhances characterization of solid tumor-chimeric antigen receptor T cell interactions DT Nguyen, R Liu, E Ogando-Rivas, A Pepe, D Pedro, S Qdaisat, ... Acta Biomaterialia 172, 466-479, 2023 | 1 | 2023 |
| DRES-13. VEGF BLOCKADE ENHANCES T REGULATORY CELL FUNCTION BY DYSREGULATING GLUTAMATE TRANSPORT IN GBM Y Long, A Karachi, A Grippin, H Tao, W Zhang, E Sayour, L Deleyrolle, ... Neuro-Oncology 20 (Suppl 6), vi78, 2018 | 1 | 2018 |
| Blocking Immune Checkpoint—LAIR1: Disrupting the LAIR1—FXIII-A—Collagen Immunosuppressive Circuit for Enhanced Antitumor Therapeutics J Huang, H Tao, D Chen, C Yang, D Nguyen, R Liu, T Liu, A Chakraborty, ... | | 2024 |
| CD70 CXCR2-Modified CAR T-Cells Against Acute Myeloid Leukemia JA Ligon, P Castillo, X Ma, L Jin, H Tao, D Nguyen, G Jobin, O Guryanova, ... Transplantation and Cellular Therapy 30 (2), S178-S179, 2024 | | 2024 |
| AN IND-ENABLED STUDY USING A NOVEL CHECKPOINT BLOCKADE OF LAIR1 FOR GLIOBLASTOMA THERAPY H Tao, D Chen, C Yang, D Nguyen, A Pepe, D Pedro, L Jin, R Liu, T Liu, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| 269 CAR T cell production expands endogenous T cell repertoire recognizing additional tumor antigen (s) A Hou, L Jin, H Tao, DA Mitchell, J Huang Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| EXTH-57. IDENTIFICATION OF NOVEL IMMUNE CHECKPOINT MOLECULE IN GLIOMA, LAIR1 H Tao, D Chen, C Yang, L Jin, C Von Roemeling, H Mendez-Gomez, ... Neuro-Oncology 24 (Supplement_7), vii222-vii222, 2022 | | 2022 |
| CBIO-16. DOSE INTENSIFIED TEMOZOLOMIDE IMPROVES INFILTRATION OF CD70 CAR T CELLS INTO THE GBM TUMOR MICROENVIRONMENT A Karachi, J Huang, H Tao, F Dastmalchi, L Jin, D Mitchell, M Rahman Neuro-Oncology 23 (Suppl 6), vi30, 2021 | | 2021 |
| IMMU-38. PRECLINICAL VALIDATION AND MANUFACTURE OF IL-8 RECEPTOR-MODIFIED CD70 CAR T CELLS FOR CLINICAL TRIAL L Jin, H Tao, M Na, A Karachi, H Mendez-Gomez, F Weidert, A Hou, ... Neuro-Oncology 22 (Supplement_2), ii113-ii113, 2020 | | 2020 |
| Toxicology Study of IL-8 Receptor-Modified CD70 CAR T Cells for Clinical Trials L Jin, H Tao, M Na, A Karachi, H Mendez-Gomez, F Weidert, A Hou, ... MOLECULAR THERAPY 28 (4), 548-548, 2020 | | 2020 |
| TMIC-49. ABROGATING CD70 EXPRESSION IN GBM RESULTS IN A REDUCED IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT H Tao, L Jin, H Mendez-Gomez, Y Long, M Na, A Hou, A Karachi, Z Lin, ... Neuro-Oncology 21 (Supplement_6), vi258-vi258, 2019 | | 2019 |
| IMMU-26. RADIATION AND TEMOZOLOMIDE UP-REGULATES CD70 EXPRESSION AND ENHANCES CAR T-CELL RECOGNITION IN GBM M Na, L Jin, H Tao, A Hou, A Karachi, Z Lin, L Deleyrolle, E Sayour, ... Neuro-Oncology 21 (Suppl 6), vi124, 2019 | | 2019 |
| IMMU-15. A UNIQUE SELF-STIMULATIVE PROPERTY OF CD70 CAR ADVANCES T CELL FUNCTION AND ANTI-TUMOR RESPONSE IN GLIOBLASTOMA L Jin, A Hou, H Tao, A Karachi, M Na, Z Lin, L Deleyrolle, E Sayour, ... Neuro-Oncology 21 (Suppl 6), vi122, 2019 | | 2019 |
| IMMU-56. CXCR1/2 MODIFIED CARs CO-OPT RADIATION-INDUCED IL-8 FOR ENHANCED CHEMOTAXIS OF THE CAR T CELLS AND MAXIMAL ANTI-TUMOR EFFICACY L Jin, H Tao, W Zhang, Y Long, K Dyson, A Karachi, L Deleyrolle, ... Neuro-Oncology 20 (suppl_6), vi134-vi134, 2018 | | 2018 |
